|
⚲
|
| Keyboard |
| Wilcox Gary
✚
|
|
|---|---|
| CIK # | 0001222257 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001222257] | |
| 4 | [0001222257] | |
| SC 13D | [0001222257] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Wilcox Gary | Cocrystal Pharma Inc | [2014-12-05] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Biozone Pharmaceuticals Inc | |
| Wilcox Gary |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biozone Pharmaceuticals Inc COCP
Stock Options (Right to Buy) · derivative
|
2020-06-22 | Grant | 200,000 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
Stock Options (Right to Buy) · derivative
|
2018-09-21 | Grant | 200,000 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2016-09-01 | Buy | 10,000 | $0.41 | 4,100 |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2016-03-15 | Buy | 49,020 | $0.51 | 25,000 |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2015-03-25 | Buy | 54,348 | $0.92 | 50,000 |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2015-03-03 | Option exercise | 16,835,237 | ||
|
Biozone Pharmaceuticals Inc COCP
Series B Preferred Stock · derivative
|
2015-03-03 | Option exercise | 82,090 |